As a result, Telix's 2025 half-year and annual financial results will be presented in USD. For comparative purposes, the Company's reviewed or audited restated historical information will be included in the half-year report for the six months ending 30 June 2025 and in the Annual Report for the year ending 31 December 2025. About Telix Pharmaceuticals Limited Telix Pharmaceuticals Limited ACN 616 620 369 55 Flemington Road North Melbourne Victoria, 3051 Australia ASX ANNOUNCEMENT Telix Announces Change in R ...